Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 17, 2008, Pages 4868-4871

  Demaray, Jeffrey A ^a   Thuener, Jason E ^a   Dawson, Matthew N ^a   Sucheck, Steven J ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Antibacterial; Antimycobacterial; One pot; Oxazolidinone

Indexed keywords

3 [(4 ACETYLPHENYL) 5 (1H 1,2,3 TRIAZOL 1 YL)METHYL]OXAZOLIDIN 2 ONE; BROMIDE; BROMINE DERIVATIVE; EPIBROMOHYDRIN; ISOCYANIC ACID DERIVATIVE; ISONIAZID; OXAZOLIDINONE DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CATALYSIS; CONTROLLED STUDY; CYCLOADDITION; DRUG SCREENING; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; NONHUMAN; ONE POT SYNTHESIS;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; ENTEROCOCCUS FAECALIS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM SMEGMATIS; OXAZOLIDINONES; TRIAZOLES;

BACILLUS SUBTILIS; ENTEROCOCCUS FAECALIS; MYCOBACTERIUM SMEGMATIS;

EID: 49849101027     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.07.087     Document Type: Article

References (48)

1. Kan J.P., Malnoe A., and Strolin Benedetti M. J. Pharm. Pharmacol. 30 (1978) 190
2. Moureau F., Wouters J., Vercauteren D.P., Collin S., Evrard G., Durant F., Ducrey F., Koenig J.J., and Jarreau F.X. Eur. J. Med. Chem. 27 (1992) 939
3. Curet O., Damoiseau G., Aubin N., Sontag N., Rovei V., and Jarreau F.X. J. Pharm. Exp. Ther. 277 (1996) 253
4. Ramsay R.R., and Gravestock M.B. Mini-Rev. Med. Chem. 3 (2003) 129
5. Gante J., Juraszyk H., Raddatz P., Wurziger H., Bernotat-Danielowski S., Melzer G., and Rippmann F. Lett. Pep. Sci. 2 (1995) 135
6. Aschwanden W., Kyburz E., and Schoenholzer P. Helv. Chim. Acta 59 (1976) 1245
7. Pruecher H., Gottschlich R., Haase A., Stohrer M., and Seyfried C. Bioorg. Med. Chem. Lett. 2 (1992) 165
8. Slee A.M., Wuonola M.A., McRipley R.J., Zajac I., Zawada M.J., Bartholomew P.T., Gregory W.A., and Forbes M. Antimicrob. Agents Chemother. 31 (1987) 1791
9. Gregory W.A., Brittelli D.R., Wang C.-L., Wuonola M.A., McRipley R.J., Eustice D.C., Eberly V.S., Bartholomew P.T., Slee A.M., and Forbes M. J. Med. Chem. 32 (1989) 1673
10. Barbachyn M.R., and Ford C.W. Angew. Chem. Int. Ed. 42 (2003) 2010
11. Zappia G., Menendez P., Delle Monache G., Misiti D., Nevola L., and Botta B. Mini-Rev. Med. Chem. 7 (2007) 389
12. Dyen M.E., and Swern D. Chem. Rev. 67 (1967) 197
13. Ager D.J., Prakash I., and Schaad D.R. Aldrichim. Acta 30 (1997) 3
14. Zappia G., Gacs-Baitz E., Delle Monache G., Misiti D., Nevola L., and Botta B. Curr. Org. Syn. 4 (2007) 81
15. Clemett D., and Markham A. Drugs 59 (2000) 815
16. Perry C.M., and Javis B. Drugs 61 (2001) 525
17. Norrby R. Exp. Opin. Pharmacother. 2 (2001) 293
18. Stevens D.L., Herr D., Lampiris H., Hunt J.L., Batts D.H., and Hafkin B. Clin. Infect. Dis. 34 (2002) 1481
19. Ashtekar D.R., Costa-Periera R., Shrinivasan T., Iyyer R., Vishvanathan N., and Rittel W.S. Diagn. Microbiol. Infect. Dis. 14 (1991) 465
20. Cynamon M.H., Klemens S.P., Sharpe C.A., and Chase S. Antimicrob. Agents Chemother. 43 (1999) 189
21. Wallace Jr. R.J., Brown-Elliott B.A., Ward S.C., Crist C.J., Mann L.B., and Wilson R.W. Antimicrob. Agents Chemother. 45 (2001) 764
22. Sood R., Bhadauriya T., Rao M., Gautam R., Barman S., Malhotra T.K., Upadhyay D.J., and Rattan A. Infect. Dis. Drug Targets 6 (2006) 343
23. Phillips O.A., Udo E.E., Ali A.A.M., and Al-Hassawi N. Bioorg. Med. Chem. 11 (2003) 35
24. Reck F., Zhou F., Girardot M., Kern G., Eyermann C.J., Hales N.J., Ramsay R.R., and Gravestock M.B. J. Med. Chem. 48 (2005) 499
25. Hauck S.I., Cederberg C., Doucette A., Grosser L., Hales N.J., Poon G., and Gravestock M.B. Bioorg. Med. Chem. Lett. 17 (2007) 337
26. Phillips O.A., Udo E.E., Ali A.A.M., and Samuel S.M. Eur. J. Med. Chem. 42 (2007) 214
27. Speranza G.P., and Peppel W.J. J. Org. Chem. 23 (1958) 1922
28. Lichtenwvalter, M.; Cooper, J. F. Jefferson Chemical Co., Inc., U.S. Patent 2,773,070, December 4, 1956.
29. Ross W.C.J. J. Chem. Soc. (1950) 2257
30. Herweh J.E., and Kauffman W.J. Tetrahedron Lett. 12 (1971) 809
31. Buchstaller H.-P. J. Comb. Chem. 5 (2003) 789
32. Shibata I., Baba A., Iwasaki H., and Matsuda H. J. Org. Chem. 51 (1986) 2177
33. Qian C., and Zhu D. Synlett (1994) 129
34. Weiner M. J. Org. Chem. 26 (1961) 951
35. Okumoto S., and Yamabe S. J. Comp. Chem. 22 (2001) 316
36. Huisgen R. In: Padwa A. (Ed). 1,3-Dipolar Cycloaddition Chemistry (1984), Wiley, New York 1-176 Chapter 1
37. Padwa A. In: Trost B.M., and Fleming I. (Eds). Comprehensive Organic Synthesis Vol. 4 (1991), Pergamon, Oxford 1069-1109
38. Gothelf K.V., and Jørgensen K.A. Chem. Rev. 98 (1998) 863
39. Kolb H.C., Finn M.G., and Sharpless K.B. Angew. Chem. Int. Ed. 40 (2001) 2004
40. Rostovtsev V.V., Green L.G., Fokin V.V., and Sharpless K.B. Angew. Chem. Int. Ed. 41 (2002) 2596
41. Tornoe C., Christensen C., and Meldal M. J. Org. Chem. 67 (2002) 3057
42. Maksikova A.V., Serebryakova E.S., Tikhonova L.G., and Vereshchagin L.I. Chem. Heterocycl. Compd. (1980) 1284
43. Appukkuttan P., Dehaen W., Fokin V.V., and Van der Eycken E. Org. Lett. 6 (2004) 4223
44. Molander G.A., and Ham J. Org. Lett. 8 (2006) 2767
45. Broggi B., Di{dotless}́ez-González S., Petersen J.L., Berteina-Raboin S., Nolan S.P., and Agrofoglio L.A. Synthesis (2008) 141
46. National Committee for Clinical Laboratory Standards. Approved Standard: M2-A7. Performance Standards for Antimicrobial Disk Susceptibility Tests, 7th ed. National Committee for Clinical Laboratory Standards: Wayne, PA, 2000.
47. National Committee for Clinical Laboratory Standards. Approved Standard: M7-A6. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 6th ed. National Committee for Clinical Laboratory Standards: Wayne, PA, 2003.
48. Mosmann T. J. Immunol. Meth. 65 (1983) 55